NCT02505841

Brief Summary

The transversus abdominis plane (TAP) block is a regional anesthetic technique for post operative pain control after abdominal surgical procedures. Its effectiveness in children undergoing laparoscopic appendectomy has not been demonstrated. The investigators evaluate its analgesic efficacy over the first 24 post operative hours.

Trial Health

43
At Risk

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
240

participants targeted

Target at P75+ for not_applicable

Timeline
Completed

Started May 2015

Typical duration for not_applicable

Geographic Reach
1 country

1 active site

Status
unknown

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

May 1, 2015

Completed
Same day until next milestone

Primary Completion

Last participant's last visit for primary outcome

May 1, 2015

Completed
2 months until next milestone

First Submitted

Initial submission to the registry

June 22, 2015

Completed
1 month until next milestone

First Posted

Study publicly available on registry

July 22, 2015

Completed
1.9 years until next milestone

Study Completion

Last participant's last visit for all outcomes

June 1, 2017

Completed
Last Updated

July 22, 2015

Status Verified

May 1, 2015

Enrollment Period

Same day

First QC Date

June 22, 2015

Last Update Submit

July 20, 2015

Conditions

Keywords

AppendectomyLaparoscopypediatric surgery

Outcome Measures

Primary Outcomes (1)

  • Painkiller of help consumption

    Quantity of analgesic of help (Nalbuphine, Nubain®, Dupont Pharma, Paris, France) taken after the surgery.

    up to 24 hours after surgery

Secondary Outcomes (2)

  • Pain intensity after surgery

    up to 24 hours

  • First demand of analgesic of help

    up to 12 hours

Study Arms (3)

Group 1

ACTIVE COMPARATOR

Curare: Atracurium injection at 0.5 mg/kg

Drug: Curare

Group 2

EXPERIMENTAL

TAP block and curare: Ultrasound-guided transversus abdominis plane block wih Ropivacaine injection 0.2% at 0.3 ml/kg then atracurium injection at 0.5 mg/kg

Other: TAP block with RopivacaineDrug: Curare

Group 3

EXPERIMENTAL

TAP block: Ultrasound-guided transversus abdominis plane block wih Ropivacaine injection 0.2% at 0.3 ml/kg

Other: TAP block with Ropivacaine

Interventions

Ultrasound-guided transversus abdominis plane block wih Ropivacaine injection 0.2% at 0.3 ml/kg

Also known as: Transversus abdominis plane (TAP) block with ropivacaine
Group 2Group 3
CurareDRUG

Atracurium injection at 0.5 mg/kg at least 3 minutes before the surgical incision

Also known as: Succinylcholine
Group 1Group 2

Eligibility Criteria

Age1 Year - 12 Years
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17)

You may qualify if:

  • Patient hospitalized in surgery and infantile anesthesia unit or admitted in emergencies for an laparoscopic appendectomy surgery.
  • Patient whose general state corresponds to the classification of the American Society of Anesthesiologists (ASA) I to II
  • Patient member in a national insurance scheme

You may not qualify if:

  • Patient with drilled appendicitis or peritonitis
  • Patient with a contraindication to local anesthesics
  • Patient with a contraindication to TAP block
  • Patient with allergies or known hypersensitivity to curare

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

CHRU Montpellier

Montpellier, 34295, France

Location

MeSH Terms

Interventions

RopivacaineDental OcclusionCurareSuccinylcholine

Intervention Hierarchy (Ancestors)

AnilidesAmidesOrganic ChemicalsAniline CompoundsAminesDentistryDental Physiological PhenomenaDigestive System and Oral Physiological PhenomenaPlant ExtractsPlant PreparationsBiological ProductsComplex MixturesCholineTrimethyl Ammonium CompoundsQuaternary Ammonium CompoundsSuccinatesDicarboxylic AcidsAcids, AcyclicCarboxylic AcidsOnium Compounds

Study Officials

  • Maud MM Maniora, MD

    Montpellier University Hospital

    PRINCIPAL INVESTIGATOR

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
PARTICIPANT, CARE PROVIDER
Purpose
PREVENTION
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

June 22, 2015

First Posted

July 22, 2015

Study Start

May 1, 2015

Primary Completion

May 1, 2015

Study Completion

June 1, 2017

Last Updated

July 22, 2015

Record last verified: 2015-05

Locations